These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

59 related items for PubMed ID: 3364813

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Metabolism of benzo(a)pyrene by subcellular fractions of rat liver: evidence for similar patterns of cytochrome P-450 in rough and smooth endoplasmic reticulum but not in nuclei and plasma membrane.
    Oesch F, Bentley P, Golan M, Stasiecki P.
    Cancer Res; 1985 Oct; 45(10):4838-43. PubMed ID: 3875401
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.
    Pichard L, Fabre I, Fabre G, Domergue J, Saint Aubert B, Mourad G, Maurel P.
    Drug Metab Dispos; 1990 Oct; 18(5):595-606. PubMed ID: 1981707
    [Abstract] [Full Text] [Related]

  • 6. Drug control of steroid metabolism by the hepatic endoplasmic reticulum.
    Feuer G.
    Drug Metab Rev; 1983 Oct; 14(6):1119-44. PubMed ID: 6373207
    [Abstract] [Full Text] [Related]

  • 7. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes.
    Wada O, Yano Y.
    Rev Environ Health; 1974 Oct; 1(4):261-82. PubMed ID: 4617260
    [No Abstract] [Full Text] [Related]

  • 8. N-benzylimidazole, a high magnitude inducer of rat hepatic cytochrome P-450 exhibiting both polycyclic aromatic hydrocarbon- and phenobarbital-type induction of phase I and phase II drug-metabolizing enzymes.
    Papac DI, Franklin MR.
    Drug Metab Dispos; 1988 Oct; 16(2):259-64. PubMed ID: 2898344
    [Abstract] [Full Text] [Related]

  • 9. Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes.
    You L.
    Chem Biol Interact; 2004 Apr 15; 147(3):233-46. PubMed ID: 15135080
    [Abstract] [Full Text] [Related]

  • 10. Failure in drug development: the role of inhibition and induction of cytochrome P450 enzymes.
    Hengstler JG, Bolt HM.
    Arch Toxicol; 2008 Oct 15; 82(10):665-6. PubMed ID: 18751968
    [No Abstract] [Full Text] [Related]

  • 11. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes.
    Szakács T, Veres Z, Vereczkey L.
    Pol J Pharmacol; 2001 Oct 15; 53(1):11-9. PubMed ID: 11785906
    [Abstract] [Full Text] [Related]

  • 12. Metabolism-based drug-drug interactions: what determines individual variability in cytochrome P450 induction?
    Tang C, Lin JH, Lu AY.
    Drug Metab Dispos; 2005 May 15; 33(5):603-13. PubMed ID: 15673596
    [Abstract] [Full Text] [Related]

  • 13. Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs.
    Masubuchi Y, Horie T.
    Crit Rev Toxicol; 2007 Jun 15; 37(5):389-412. PubMed ID: 17612953
    [Abstract] [Full Text] [Related]

  • 14. Hexachlorobenzene and substituted pentachlorobenzenes (X-C6Cl5) as inducers of hepatic cytochrome P-450-dependent mono-oxygenases.
    Li SM, Denomme MA, Leece B, Safe S, Dutton D, Parkinson A, Thomas PE, Ryan D, Bandiera S, Reik LM.
    IARC Sci Publ; 1986 Jun 15; (77):527-34. PubMed ID: 3596752
    [Abstract] [Full Text] [Related]

  • 15. Nutritional parameters that alter hepatic drug metabolism, conjugation, and toxicity.
    Bidlack WR, Brown RC, Mohan C.
    Fed Proc; 1986 Feb 15; 45(2):142-8. PubMed ID: 3510912
    [Abstract] [Full Text] [Related]

  • 16. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. II. Participation of CYP isoenzymes in the metabolism of endogenous substances and drugs.
    Tomaszewski P, Kubiak-Tomaszewska G, Pachecka J.
    Acta Pol Pharm; 2008 Feb 15; 65(3):307-18. PubMed ID: 18646550
    [Abstract] [Full Text] [Related]

  • 17. Assessment of enzyme induction and enzyme inhibition in humans: toxicological implications.
    Park BK, Kitteringham NR.
    Xenobiotica; 1990 Nov 15; 20(11):1171-85. PubMed ID: 2275213
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers.
    Bast A, Savenije-Chapel EM, Kroes BH.
    Xenobiotica; 1984 May 15; 14(5):399-408. PubMed ID: 6089451
    [Abstract] [Full Text] [Related]

  • 19. [Role of monoxygenases in the metabolism of drugs in the human fetus and newborn infant].
    Cresteil T, Leroux JP.
    Arch Fr Pediatr; 1982 May 15; 39(7):463-70. PubMed ID: 6816186
    [Abstract] [Full Text] [Related]

  • 20. Induction of drug metabolism: species differences and toxicological relevance.
    Graham MJ, Lake BG.
    Toxicology; 2008 Dec 30; 254(3):184-91. PubMed ID: 18824059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.